Accenture Plc (ACN)
198.90
-13.40
(-6.31%)
USD |
NYSE |
Oct 02, 16:00
199.11
+0.21
(+0.11%)
After-Hours: 20:00
Accenture R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical R&D to Revenue (TTM) Data
| Date | Value |
|---|---|
| February 29, 2004 | -- |
| November 30, 2003 | -- |
| August 31, 2003 | -- |
| May 31, 2003 | -- |
| Date | Value |
|---|---|
| February 28, 2003 | -- |
| November 30, 2002 | -- |
| August 31, 2002 | -- |
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.
R&D to Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median